Ag Novartis, 10% Owner at Aeglea BioTherapeutics, Inc. (AGLE), sold 84,210 shares at $10.11 ($847K) on 2018-05-07, disclosed to the SEC on 2018-05-09.
Open-market sale of $847k AGLE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.11 | 15,548 | $157K | 18.6% |
| 2 | $10.11 | 15,548 | $157K | 18.6% |
| 3 | $10.03 | 26,557 | $266K | 31.4% |
| 4 | $10.03 | 26,557 | $266K | 31.4% |
| Total | $10.06 avg | 84,210 | $847K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-12 | $242K | — | Filing → |
| GRTX | BUY | 2019-11-12 | $3.0M | — | Filing → |
| ARPO | SELL | 2019-04-29 | $1.4M | — | Filing → |